The Walter Reed Army Institute of Research is the largest biomedical research facility administered by the U.S. Department of Defense.

During the past decade, Walter Reed Army Institute of Research conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 11 clinical trials were completed, i.e. on average, 57.9% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 5 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Walter Reed Army Institute of Research" #1 sponsor was "U.S. Army Medical Research and Development Command" with 22 trials, followed by "Walter Reed Army Institute of Research (WRAIR)" with 7 trials sponsored, "Clovis Oncology, Inc." with 1 trials sponsored, "Emergent BioSolutions" with 1 trials sponsored and "Fraunhofer, Center for Molecular Biotechnology" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Walter Reed Army Institute of Research" #1 collaborator was "Walter Reed Army Institute of Research (WRAIR)" with 15 trials as a collaborator, "GlaxoSmithKline" with 5 trials as a collaborator, "Henry M. Jackson Foundation for the Advancement of Military Medicine" with 2 trials as a collaborator, "Ichor Medical Systems Incorporated" with 2 trials as a collaborator and "The PATH Malaria Vaccine Initiative (MVI)" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Walter Reed Army Institute of Research" are "Malaria" (8 trials), "HIV Infections" (4 trials), "Diarrhea" (3 trials), "Anger" (2 trials) and "HIV Seronegativity" (2 trials). Many other conditions were trialed in "Walter Reed Army Institute of Research" in a lesser frequency.

Most popular intervention types in "Walter Reed Army Institute of Research" are "Biological" (25 trials), "Drug" (12 trials), "Other" (9 trials), "Device" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Primaquine" (2 trials), "100μg ALFQ" (1 trials), "15 microgram VLPM01" (1 trials) and "200μg ALFQ" (1 trials). Other intervention names were less common.

The vast majority of trials in "Walter Reed Army Institute of Research" are 39 trials for "All" genders.

Currently, there are NaN active trials in "Walter Reed Army Institute of Research". 1 are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 27 completed trials in Walter Reed Army Institute of Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Walter Reed Army Institute of Research, 25 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".